As TNBC contains higher amounts of PC (32:1) and PC (30:0) compared with estrogen receptor positive and HER2 type breast cancers [13], this may indicate a poor prognosis for all TNBC types compared to other subtypes. Here, ERBB2 is linked to pachyonychia congenita.